港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

同源康医药-B

15.690

+0.0500.32%

成交量：301.05万

成交额：4,756.13万

市值：59.62亿

市盈率：-12.54

高：16.060

开：15.670

低：15.560

收：15.640

52周最高：56.550

52周最低：13.000

股本：3.80亿

香港流通股本：3.75亿

量比：0.25

换手率：0.80%

股息：- -

股息率：- -

每股收益(LYR):-1.251

净资产收益率：--

总资产收益率：-28.86%

市净率：11.65

市盈率(LYR):-12.54

市销率: 51060.30

数据加载中...

总览公司新闻公告

港股公告掘金 |华能国际电力股份上半年归母净利约92.62亿元同比增长24.26%

每日卖空追踪 | 同源康医药-B 07月29日卖空量成交2.05万股，卖空比例为0.27%

同源康医药-B(02410.HK)拟折让约19.00%配售923万股配售股份净筹约1.55亿港元

同源康医药-B拟折让约19.00%配售923万股配售股份，净筹约1.55亿港元

同源康医药-B拟折让19%配股总筹1.57亿港元加码研发与商业化布局

同源康医药-B盘中异动下午盘急速拉升5.16%

格隆汇个股放量排行榜 | 7月26日

同源康医药-B盘中异动早盘股价大涨5.00%

同源康医药-B(02410.HK)：TY-302、TY-2699a及TY-0540的I期临床试验结果获2025年欧洲肿瘤内科学会(ESMO)大会以壁报形式收录

同源康医药-B(02410)：TY-302、TY-2699a及TY-0540的I期临床试验结果获2025年欧洲肿瘤内科学会(ESMO)大会以壁报形式收录

同源康医药-B07月23日获主力加仓467.5万元

同源康医药(02410)CDK2/4抑制剂TY-00540为CDK4/6抑制剂耐药后HR+/HER2-乳腺癌带来新希望

港股异动 | 同源康医药-B(02410)尾盘急升逾7% 旗下三款创新药研究成果获ESMO 2025收录

同源康医药(02410)三款创新药研究成果获2025年ESMO大会收录

每日卖空追踪 | 同源康医药-B 07月21日卖空量成交500股，卖空比例为0.02%

同源康医药-B07月21日主力净流出123.0万元散户资金买入

同源康医药：单品依赖现象较为明显核心产品管线价值突出 | 18A药企价值解码

同源康医药-B07月16日主力净流出1.6万元散户资金买入

同源康医药-B盘中异动下午盘股价大跌5.12%

每日卖空追踪 | 同源康医药-B 07月14日卖空量成交4000股，卖空比例为0.71%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02410/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康医药-B","latestPrice":15.69,"timestamp":1756186915198,"preClose":15.64,"halted":0,"volume":3010500,"delay":0,"floatShares":375000000,"shares":380000000,"eps":-1.2507679133734688,"marketStatus":"交易中","change":0.05,"latestTime":"08-26 13:42:40","open":15.67,"high":16.06,"low":15.56,"amount":47561325,"amplitude":0.031969,"askPrice":15.71,"askSize":500,"bidPrice":15.69,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-1.2507679133734688,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":15.64,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.249844,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375000000,"roa":"-28.86%","roe":"--","lyrEps":-1.250768,"volumeRatio":0.249844,"shares":380000000,"dividePrice":0,"high":16.06,"amplitude":0.031969,"preClose":15.64,"low":15.56,"week52Low":13,"pbRate":"11.65","psRate":"51060.30","week52High":56.55,"institutionHeld":0,"latestPrice":15.69,"committee":0.666667,"eps":-1.2507679133734688,"divideRate":0,"volume":3010500,"delay":0,"ttmEps":-1.2507679133734688,"open":15.67,"prevYearClose":47.15,"prevWeekClose":15.73,"prevMonthClose":20.3,"prevQuarterClose":21.7,"fiveDayClose":18.84,"twentyDayClose":21.35,"sixtyDayClose":25.2,"earningDate":1756569600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1747584000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2025-08-25","current":-13.354956,"percent":0.976,"low":-45.171338,"twenty":-25.949863,"median":-22.318331,"eighty":-16.676594,"high":-10.104382,"avg":-22.494898,"sd":6.666208,"marketCap":5944229393},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-25","current":-13.354956,"twenty":-25.949863,"median":-22.318331,"eighty":-16.676594,"marketCap":5944229393}],"updateTime":1756186960503},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555605080","title":"港股公告掘金 |华能国际电力股份上半年归母净利约92.62亿元 同比增长24.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555605080","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555605080?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 23:13","pubTimestamp":1753802009,"startTime":"0","endTime":"0","summary":"【重大事项】创梦天地(01119)及深圳创梦与PLR Worldwide Sales Limited订立资本化协议同源康医药-B(02410)拟折让约19.00%配售923万股配售股份 净筹约1.55亿港元盛业(06069)设立新加坡国际总部及探索Web3.0生态和稳定币创新应用场景康宁杰瑞制药-B(09966)：JSKN003获美国FDA授予用于治疗GC/GEJ的孤儿药资格认定上海医药(0260","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1125","HSCEI","HSTECH","06069","00763","BK1530","YANG","BK1161","BK1529","BK1186","BK1164","BK1618","00902","BK4614","BK1586","BK1609","01901","BK1149","02410","BK1607","BK1613","BK1526","BK1506"],"gpt_icon":1},{"id":"2555051014","title":"每日卖空追踪 | 同源康医药-B 07月29日卖空量成交2.05万股，卖空比例为0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555051014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555051014?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 16:30","pubTimestamp":1753777828,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间07月29日，涨1.67%，卖空量成交2.05万股%，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729171939a4696045&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729171939a4696045&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"2555970263","title":"同源康医药-B(02410.HK)拟折让约19.00%配售923万股配售股份 净筹约1.55亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555970263","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555970263?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 07:02","pubTimestamp":1753743747,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02410","BK1574","BK1515","09939","159938","BK1161"],"gpt_icon":0},{"id":"2555702652","title":"同源康医药-B拟折让约19.00%配售923万股配售股份，净筹约1.55亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555702652","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555702652?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 07:02","pubTimestamp":1753743747,"startTime":"0","endTime":"0","summary":"假设于本公告日期至交割日期期间已发行股份数目并无变动，则配售事项项下的923万股配售股份相当于经配发及发行配售股份扩大后的已发行H股数目的约2.46 %及已发行股份数目的约2.43%。假设所有配售股份获悉数配售及待完成后，预期配售事项所得款项总额及所得款项净额将分别约为1.57亿港元及1.55亿港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02410","159938","BK1161","09939","BK1515"],"gpt_icon":1},{"id":"2555076704","title":"同源康医药-B拟折让19%配股总筹1.57亿港元 加码研发与商业化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2555076704","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555076704?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 06:38","pubTimestamp":1753742305,"startTime":"0","endTime":"0","summary":"格隆汇7月29日丨同源康医药-B发布公告，2025年7月28日，公司与配售代理订立配售协议，据此，配售代理有条件同意作为公司的配售代理，按尽力基准促使承配人按每股配售股份17.01港元的配售价购买923万股配售股份。预期配售代理将促使不少于6名承配人认购配售股份。假设所有配售股份获悉数配售及待完成后，预期配售事项最高所得款项总额及所得款项净额将分别约为1.57亿港元及1.55亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072906383994c01a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072906383994c01a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02410","BK1574","BK1515","09939"],"gpt_icon":1},{"id":"2554251347","title":"同源康医药-B盘中异动 下午盘急速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554251347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554251347?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 14:56","pubTimestamp":1753685802,"startTime":"0","endTime":"0","summary":"2025年07月28日下午盘14时56分，同源康医药-B股票出现波动，股价急速上涨5.16%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。同源康医药-B股票所在的生物技术行业中，整体涨幅为2.34%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281456429722a7aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281456429722a7aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09939","02410","BK1515"],"gpt_icon":0},{"id":"2554161997","title":"格隆汇个股放量排行榜 | 7月26日","url":"https://stock-news.laohu8.com/highlight/detail?id=2554161997","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554161997?lang=zh_cn&edition=fundamental","pubTime":"2025-07-26 17:30","pubTimestamp":1753522203,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日中国光大绿色环保(01257)、中国国航(00753)、互太纺织(01382)、微创医疗(00853)、重庆农村商业银行(03618)、广联科技控股(02531)、华虹半导体(01347)、光大环境(00257)、滨江服务(03316)、嘉鼎国际集团(08153)、元续科技(08637)、万顺瑞强集团(08427)、天德化工(00609)、基石科技控股(08391)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/26173052004150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09699","01618","02689","00363","01525","09979","01733","03993","03833","03931","00358","01760","02338","01030","02209","03996","02628","00023","08299","09676","03836","06818","09901","01776","02410","00670","01223","09896","08635","09666","09658","06881","01258","01252","01361","02068","02419","08637","01799","02175","03938","00017","01257","02600","00384","08153","00038","02380","02057"],"gpt_icon":1},{"id":"2554732832","title":"同源康医药-B盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554732832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554732832?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 09:32","pubTimestamp":1753407161,"startTime":"0","endTime":"0","summary":"2025年07月25日早盘09时32分，同源康医药-B股票出现波动，股价快速拉升5.00%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，维立志博-B、中国抗体-B、奥星生命科技涨幅较大，振幅较大的相关个股有维立志博-B、奥星生命科技、北海康成-B，振幅分别为21.00%、8.89%、5.33%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509324194b96701&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509324194b96701&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","02410","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2553789679","title":"同源康医药-B(02410.HK)：TY-302、TY-2699a及TY-0540的I期临床试验结果获2025年欧洲肿瘤内科学会(ESMO)大会以壁报形式收录","url":"https://stock-news.laohu8.com/highlight/detail?id=2553789679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553789679?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 22:51","pubTimestamp":1753368686,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1515","BK1161","03347","BK1583","BK1141","159938","BK1576","02410","TY","09939"],"gpt_icon":0},{"id":"2553678967","title":"同源康医药-B(02410)：TY-302、TY-2699a及TY-0540的I期临床试验结果获2025年欧洲肿瘤内科学会(ESMO)大会以壁报形式收录","url":"https://stock-news.laohu8.com/highlight/detail?id=2553678967","media":"智通财经","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553678967?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 22:51","pubTimestamp":1753368686,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 发布公告，公司自主研发的三款临床产品TY-302、 TY-2699a及TY-0540的I期临床试验结果，正式获2025年欧洲肿瘤内科学会 大会以壁报形式收录。初步临床数据显示，TY-2699a在同类剂量水平下兼具优异安全性和初步疗效。TY-0540是一种选择性CDK2抑制剂，拟用于治疗乳腺癌、卵巢癌及前列腺癌等其他实体瘤。欧洲肿瘤内科学会成立于1975年，是全球领先的肿瘤学专业学术组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1141","03347","BK1574","02410","BK1576","09939","TY","BK1161","BK1583","BK1515"],"gpt_icon":0},{"id":"2553921319","title":"同源康医药-B07月23日获主力加仓467.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553921319","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553921319?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 16:15","pubTimestamp":1753258558,"startTime":"0","endTime":"0","summary":"07月23日, 同源康医药-B股价涨2.83%，报收19.64元，成交金额8716.9万元，换手率1.22%，振幅7.80%，量比1.55。同源康医药-B今日主力资金净流入467.5万元，上一交易日主力净流入88.1万元。该股近5个交易日上涨3.74%，主力资金累计净流入403.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1898.1万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723170417a6bcef56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723170417a6bcef56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","02410","BK1515","BK1574"],"gpt_icon":0},{"id":"2553931212","title":"同源康医药(02410)CDK2/4抑制剂TY-00540为CDK4/6抑制剂耐药后HR+/HER2-乳腺癌带来新希望","url":"https://stock-news.laohu8.com/highlight/detail?id=2553931212","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553931212?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 11:29","pubTimestamp":1753241391,"startTime":"0","endTime":"0","summary":"同源康TY-00540：全球领先的CDK2/4双靶点抑制剂，靶向耐药关键机制CDK4/6抑制剂耐药的核心机制之一，是肿瘤细胞通过上调CDK2活性绕过CDK4/6抑制，驱动细胞周期持续进展。TY-00540通过同时抑制CDK4/6和CDK2双重阻断肿瘤细胞周期进程，从而克服CDK4/6抑制剂耐药。综上，TY-00540的药物研发处于世界领先位置，将有望填补HR+/HER2-乳腺癌CDK4/6耐药后无有效药物可用的空白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","TY","BK1574","BK0188","02410","000876","BK0196","BK0238","BK0187","HR","BK0183","09939","BK1227","159938","BK0012","BK4225","BK1161","00540","BK4203","BK1515"],"gpt_icon":0},{"id":"2553238896","title":"港股异动 | 同源康医药-B(02410)尾盘急升逾7% 旗下三款创新药研究成果获ESMO 2025收录","url":"https://stock-news.laohu8.com/highlight/detail?id=2553238896","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553238896?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 15:49","pubTimestamp":1753170580,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B尾盘急升逾7%，截至发稿，涨5.53%，报19.08港元，成交额6276.81万港元。消息面上，同源康医药今日宣布，公司自主研发的三款创新药物——CDK2/4抑制剂TY-00540、CDK7抑制剂TY-2699a及CDK4/6抑制剂TY-302的I期临床试验结果，正式获2025年欧洲肿瘤内科学会大会以壁报形式收录。此外，同源康医药6月9日正式获纳入恒生生物科技指数成份股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","02410","BK1515","06978","BK1574","BK1161","159992","159938"],"gpt_icon":0},{"id":"2553282554","title":"同源康医药(02410)三款创新药研究成果获2025年ESMO大会收录","url":"https://stock-news.laohu8.com/highlight/detail?id=2553282554","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553282554?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 14:28","pubTimestamp":1753165739,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药今日宣布，公司自主研发的三款创新药物——CDK2/4抑制剂TY-00540、CDK7抑制剂TY-2699a及CDK4/6抑制剂TY-302的I期临床试验结果，正式获2025年欧洲肿瘤内科学会大会以壁报形式收录。潜在\"同类最佳\"CDK7抑制剂TY-2699a彰显治疗优势TY-2699a是同源康医药开发的新一代CDK7抑制剂，在25种CDK家族激酶筛选中展现出对CDK7的高度选择性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","159992","02410","09939","BK1574","BK1161","BK1515","06978"],"gpt_icon":0},{"id":"2553474014","title":"每日卖空追踪 | 同源康医药-B 07月21日卖空量成交500股，卖空比例为0.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553474014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553474014?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 16:30","pubTimestamp":1753086631,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间07月21日，跌5.14%，卖空量成交500股%，较上一交易日减少75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721171858a6b79ac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721171858a6b79ac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","09939","BK1161","02410"],"gpt_icon":0},{"id":"2553307471","title":"同源康医药-B07月21日主力净流出123.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2553307471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553307471?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 16:15","pubTimestamp":1753085749,"startTime":"0","endTime":"0","summary":"07月21日, 同源康医药-B股价跌5.14%，报收18.08元，成交金额5065.4万元，换手率0.75%，振幅5.56%，量比1.34。同源康医药-B今日主力资金净流出123.0万元，上一交易日主力净流入143.6万元。该股近5个交易日下跌9.54%，主力资金累计净流出133.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1531.1万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165822a6b78bfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165822a6b78bfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","09939","BK1161","02410"],"gpt_icon":0},{"id":"2552452310","title":"同源康医药：单品依赖现象较为明显 核心产品管线价值突出 | 18A药企价值解码","url":"https://stock-news.laohu8.com/highlight/detail?id=2552452310","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552452310?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 14:03","pubTimestamp":1752818580,"startTime":"0","endTime":"0","summary":"而对于投资者而言，对港股18A生物医药企业的评估需穿透传统财务指标，聚焦三大核心维度，包括现金生存周期、临床管线价值以及知识产权护城河。由此可见，IPO募资补血后公司资产负债情况较好，短期无偿债压力。公司处于Ⅲ期临床、申报上市阶段、已上市的药物占比为8.3%，单品依赖现象较为明显。知识产权方面，截至报告期末，同源康医药累计获得248项专利和25项商标，且未发生与知识产权相关的诉讼案件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718140603a452ad69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718140603a452ad69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","02410","09939"],"gpt_icon":0},{"id":"2552124555","title":"同源康医药-B07月16日主力净流出1.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2552124555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552124555?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 16:15","pubTimestamp":1752653754,"startTime":"0","endTime":"0","summary":"07月16日, 同源康医药-B股价跌2.50%，报收18.74元，成交金额2032.2万元，换手率0.29%，振幅5.20%，量比0.88。同源康医药-B今日主力资金净流出1.6万元，上一交易日主力净流入20.2万元。该股近5个交易日下跌5.13%，主力资金累计净流入176.4万元；近20日主力资金累计净流入4753.7万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170924a44e5640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170924a44e5640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","BK1574","BK1161","02410"],"gpt_icon":0},{"id":"2551155538","title":"同源康医药-B盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551155538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551155538?lang=zh_cn&edition=fundamental","pubTime":"2025-07-15 13:01","pubTimestamp":1752555709,"startTime":"0","endTime":"0","summary":"2025年07月15日下午盘13时01分，同源康医药-B股票出现异动，股价大幅下跌5.12%。截至发稿，该股报18.900港元/股，成交量106.15万股，换手率0.29%，振幅5.52%。同源康医药-B股票所在的生物技术行业中，整体涨幅为1.52%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715130149a6aa4174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715130149a6aa4174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"2551186246","title":"每日卖空追踪 | 同源康医药-B 07月14日卖空量成交4000股，卖空比例为0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551186246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551186246?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 16:30","pubTimestamp":1752481828,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间07月14日，涨0.5%，卖空量成交4000股%，较上一交易日减少33.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714172554a4498f2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714172554a4498f2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09939","BK1515","02410"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":146,"code":"91000000","status":"200"}]}}